Vaccine-Elicited Antibody Responses to Influenza H3N2 Subclade K
Wang, L.; Nangle, S.; Waller-Pulido, A.; McMahan, K.; Pereira, J.; Chaudhari, J.; Barrett, L.; Bhowmik, R.; Ferrugia, K.; Ramsamooj, R.; Sordillo, E.; Simon, V.; van Bakel, H.; Mostafa, H.; Pekosz, A.; Collier, A.-r.; Barouch, D.
Show abstract
Influenza H3N2 subclade K (J.2.4.1) is a genetic branch of H3N2 with 11 mutations in hemagglutinin and currently represents the dominant circulating influenza strain. We evaluated antibody responses to H3N2 subclade K before and after influenza vaccination in 46 healthy individuals. Our data show that baseline antibody responses to two H3N2 subclade K variants were lower than to other H1N1 and H3N2 strains and that antibody responses following vaccination were also less robust to the H3N2 subclade K variants. These data indicate that the H3N2 subclade K strain partially evades both prior H3N2 immunity and the current inactivated influenza vaccine.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Low levels of H5N1 HA and NA antibodies in the human population are boosted by seasonal A/H1N1 infection but not by A/H3N2 infection or influenza vaccination 96%
- Imprinted anti-hemagglutinin and anti-neuraminidase antibody responses after childhood infections of A(H1N1) and A(H1N1)pdm09 influenza viruses 95%
- Mucosal Correlates of Protection after Influenza Viral Challenge of Vaccinated and Unvaccinated Healthy Volunteers 95%
Similar papers in this journal
- Impact of serum versus anticoagulant-containing plasma on influenza virusneuraminidase-based serological assays 94%
- Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice 93%
- Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam 93%
Similar papers in this journal
- Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine 93%
- Potential antigenic mismatch of the H3N2 component of the 2019 Southern Hemisphere influenza vaccine 93%
- Comprehensive mapping of neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.